GL1X · GenesisL1 explorer

MolNFT v1 · #150026 · protein

Human PARP1 (ARTD1) - catalytic domain in complex with inhibitor ME0527

6GHK · Poly [ADP-ribose] polymerase 1: “Human PARP1 (ARTD1) - catalytic domain in complex with inhibitor ME0527”. X-ray diffraction, 2 ligands (EZ2, SO4), 5 pockets (best druggability 0.81). MolNFT v1 #150026 on GenesisL1: 3D structure…

PDB
6GHK
Type
protein
Length
705 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 1
EC
2.4.2.30
UniProt
P09874
Ligands
EZ2, SO4
Pockets
5 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 38% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APoly [ADP-ribose] polymerase 1 (EC 2.4.2.30)protein35038% helix, 24% strandP09874
BPoly [ADP-ribose] polymerase 1 (EC 2.4.2.30)protein35538% helix, 24% strandP09874

Ligands and binding sites

  • EZ2 · ~{N}-[(1~{R})-1-(4-imidazol-1-ylphenyl)ethyl]-3-(4-oxidanylidene-1~{H}-quinazolin-2-yl)propanamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111680.810.83104SO4, EZ2
24240.770.8635EZ2
31020.480.8117empty
4960.450.7916empty
5650.400.8017empty

Interfaces

1 interface between chains.

  • A–B · 553 Ų buried · 9 hydrogen bonds · protein-protein

Compared structures

  • 6GHK · Human PARP1 (ARTD1) - Catalytic domain in complex with inhibitor ME0527 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.